**Trimethoprim/Sulfamethoxazole Contraindications**

- Known hypersensitivity to either drug or a past sulfa allergy

- Pregnancy (FDA pregnancy category D) - due to the inhibition of folate synthesis, which can lead to congenital abnormalities.

- Liver parenchymal damage, jaundice, and hepatic failure

- Hematological disorders

- Renal insufficiency

- Neonate less than six weeks of age

Trimethoprim/sulfamethoxazole is an American pregnancy category D medication. Use during early pregnancy has been related to congenital malformations and maternal folic acid deficiency; this may cause neural tube defects (spina bifida), urinary tract defects, oral clefts, and clubbed feet. Use during late pregnancy has been related to preterm labor. The drug also gets excreted in breast milk, and breastfeeding patients should not use trimethoprim/sulfamethoxazole during this time.

Administration of trimethoprim/sulfamethoxazole should not occur concomitantly with any of the following:

- ACE inhibitors: Risk of hyperkalemia

- Prilocaine: Risk of methemoglobinemia

- Antiarrhythmics: Risk of QTc prolongation

- Dapsone: Increases plasma levels of both drugs

- Methenamine:Â Risk of crystalluria

- Rifampin: Risk of reducing trimethoprim plasma concentrations

- Sulfonylureas

- Phenytoin: Increase in the half-life of phenytoin

- Antifolates: Risk of megaloblastic anemia

- Lamivudine, zalcitabine, and zidovudine

- Procainamide and/or amantadine

- Clozapine

- Digoxin: Increase in digoxin levels

- Diuretics: Risk of thrombocytopenia

- Ciclosporin: Risk of kidney function decline

- Spironolactone: Risk of hyperkalemia